Stress Granules in the Anti-Cancer Medications Mechanism of Action: A Systematic Scoping Review.

Asadi, Mohammad Reza; Moslehian, Marziyeh Sadat; Sabaie, Hani; Poornabi, Marziye; Ghasemi, Elham; Hassani, Mehdi; Hussen, Bashdar Mahmud; Taheri, Mohammad; Rezazadeh, Maryam

Asadi, Mohammad Reza; Moslehian, Marziyeh Sadat; Sabaie, Hani; Poornabi, Marziye; Ghasemi, Elham; Hassani, Mehdi; Hussen, Bashdar Mahmud; Taheri, Mohammad; Rezazadeh, Maryam.

Afiliação

Asadi MR; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Moslehian MS; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Sabaie H; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Poornabi M; Student Research Committee, School of Medicine, Shahroud University of Medical Science, Shahroud, Iran.
Ghasemi E; Department of Molecular Medicine and Biotechnology, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Hassani M; Student Research Committee, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Hussen BM; Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
Taheri M; Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rezazadeh M; Institute of Human Genetics, Jena University Hospital, Jena, Germany.

Front Oncol ; 11: 797549, 2021.

Article em En | MEDLINE | ID: mdl-35004322

Palavras-chave

5-fluorouracil; anti-cancer medication; bortezomib; cisplatin; doxorubicin; oxaliplatin; sorafenib; stress granule

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Qualitative_research / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google